• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Dis . High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers

tetano

Editor, Senior Moderator
J Infect Dis


. 2021 Feb 13;jiab099.
doi: 10.1093/infdis/jiab099. Online ahead of print.
High amounts of SARS-CoV-2 precede sickness among asymptomatic healthcare workers


Joakim Dillner[SUP] 1 [/SUP], K Miriam Elfstr?m[SUP] 1 [/SUP], Jonas Blomqvist[SUP] 2 [/SUP], Lars Engstrand[SUP] 1 3 4 [/SUP], Mathias Uhl?n[SUP] 4 [/SUP], Carina Eklund[SUP] 1 [/SUP], Fredrik Boulund[SUP] 3 [/SUP], Camilla Lagheden[SUP] 1 [/SUP], Marica Hamsten[SUP] 3 [/SUP], Sara Nordqvist-Kleppe[SUP] 1 [/SUP], Maike Seifert[SUP] 3 [/SUP], Cecilia Hellstr?m[SUP] 5 [/SUP], Jennie Olofsson[SUP] 5 [/SUP], Eni Andersson[SUP] 5 [/SUP], August Jernbom Falk[SUP] 5 [/SUP], Sofia Bergstr?m[SUP] 5 [/SUP], Emilie Hultin[SUP] 1 [/SUP], Elisa Pin[SUP] 5 [/SUP], Ville N Pimenoff[SUP] 1 [/SUP], Sadaf Hassan[SUP] 1 [/SUP], Anna M?nberg[SUP] 5 [/SUP], Peter Nilsson[SUP] 5 [/SUP], My Hedhammar[SUP] 6 [/SUP], Sophia Hober[SUP] 6 [/SUP], Johan Mattsson[SUP] 2 [/SUP], Laila Sara Arroyo M?hr[SUP] 1 [/SUP], Kalle Conneryd Lundgren[SUP] 2 [/SUP]



Affiliations

Abstract

Background: Whether SARS-CoV-2 positivity among symptomatic subjects reflects past or future disease may be difficult to ascertain.
Methods: We tested a cohort of 9449 employees at work at the Karolinska University Hospital, Stockholm, Sweden for SARS-CoV-2 RNA and antibodies, linked the testing results to sick leave records and determined associations with past or future sick leave using multinomial logistic regression. ClinicalTrials.gov NCT04411576.
Results: Subjects with high amounts of SARS-CoV-2 virus, as indicated by the Cycle threshold (Ct) value in the PCR, had the highest risk for sick leave in the two weeks after testing (OR 11.97 (CI 95% 6.29-22.80)) whereas subjects with low amounts of virus had the highest risk for sick leave in the past three weeks before testing (OR 6.31 (4.38-9.08)). Only 2.5% of employees were SARS-CoV-2 positive while 10.5% were positive by serology and 1.2% were positive in both tests. Serology-positive subjects were not at excess risk for future sick leave (OR 1.06 (95% CI, 0.71-1.57)).
Conclusions: High amounts of SARS-CoV-2 virus, as determined using PCR Ct values, associates with development of sickness in the next few weeks. The results support the concept that PCR Ct may be informative when testing for SARS-CoV-2 is performed.

Keywords: Coronavirus; SARS-CoV-2; antibodies; healthcare workers; sick leave.
 
Back
Top Bottom